CD4 and type 1 diabetes mellitus: Another first-generation CAR cytotoxic T lymphocytes, equipped with five modules targeting clonotypic TCRs expressed by CD4+ T cells, could eliminate pathogenic CD4+ T cells, neutralize their impact on T1DM, and reduce insulitis in the pancreas of treated NOD mice (76).